Membrane-based inverse transition cycling: An improved means for purifying plant-derived recombinant protein-elastin-like polypeptide fusions

International Journal of Molecular Sciences

Volumn 12, Issue 5, 2011, Pages 2808-2821

  Phan, Hoang Trong ^a   Conrad, Udo ^a  

^a LEIBNIZ INSTITUTE OF PLANT GENETICS AND CROP PLANT RESEARCH IPK   (Germany)

Author keywords

Avian influenza; ELPylation; H5N1; Inverse transition cycling; Nanobody; Transgenic plants

Indexed keywords

ELASTIN; ELASTIN LIKE POLYPEPTIDE; HEMAGGLUTININ; NEUTRALIZING ANTIBODY; POLYPEPTIDE; SIALIDASE; UNCLASSIFIED DRUG; HEMAGGLUTININ, AVIAN INFLUENZA A VIRUS; HYBRID PROTEIN; INFLUENZA VIRUS HEMAGGLUTININ; VIRUS ANTIGEN;

ANALYTIC METHOD; ANTIBODY PRODUCTION; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; MEMBRANE BASED INVERSE TRANSITION CYCLING; NONHUMAN; PLANT LEAF; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; PROTEIN PURIFICATION; PROTEIN SYNTHESIS; PROTEIN TARGETING; TOBACCO; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETIC TRANSFORMATION; GENETICS; INFLUENZA VIRUS A H5N1; ISOLATION AND PURIFICATION; METABOLISM; TRANSGENIC PLANT;

AVES; NICOTIANA OBTUSIFOLIA; NICOTIANA TABACUM;

ANTIGENS, VIRAL; ELASTIN; ENZYME-LINKED IMMUNOSORBENT ASSAY; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; INFLUENZA A VIRUS, H5N1 SUBTYPE; NEURAMINIDASE; PLANT LEAVES; PLANTS, GENETICALLY MODIFIED; RECOMBINANT FUSION PROTEINS; TOBACCO; TRANSFORMATION, GENETIC;

EID: 79957837910     PISSN: None     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms12052808     Document Type: Article

References (41)

1. Curtiss, R.I.; Cardineau, C.A. Oral immunisation by transgenic plants. U.S. Patent 5,679,880, 1990.
2. Hiatt, A.; Caffferkey, R.; Bowdish, K. Production of antibodies in transgenic plants. Nature 1989, 342, 76-78.
3. Ma, J.K.; Drake, P.M.; Christou, P. The production of recombinant pharmaceutical proteins in plants. Nat. Rev. Genet. 2003, 4, 794-805.
4. Ma, J.K.; Barros, E.; Bock, R.; Christou, P.; Dale, P.J.; Dix, P.J.; Fischer, R.; Irwin, J.; Mahoney, R.; Pezzotti, M.; et al. Molecular farming for new drugs and vaccines. Current perspectives on the production of pharmaceuticals in transgenic plants. EMBO Rep. 2005, 6, 593-599.
5. Stoger, E.; Ma, J.K.; Fischer, R.; Christou, P. Sowing the seeds of success: Pharmaceutical proteins from plants. Curr. Opin. Biotechnol. 2005, 16, 167-173.
6. Streatfield, S.J.; Howard, J.A. Plant production systems for vaccines. Expert Rev. Vaccines 2003, 2, 763-775.
7. Warzecha, H.; Mason, H.S. Benefits and risks of antibody and vaccine production in transgenic plants. J. Plant Physiol. 2003, 160, 755-764.
8. Yusibov, V.; Rabindran, S. Recent progress in the development of plant derived vaccines. Expert Rev. Vaccines 2008, 7, 1173-1183.
9. Hassan, S.; van Dolleweerd, C.J.; Ioakeimidis, F.; Keshavarz-Moore, E.; Ma, J.K.C. Considerations for extraction of monoclonal antibodies targeted to different subcellular compartments in transgenic tobacco plants. Plant Biotechnol. J. 2008, 6, 733-748.
10. Hood, E.E.; Woodard, S.L.; Horn, M.E. Monoclonal antibody manufacturing in transgenic plants-myths and realities. Curr. Opin. Biotechnol. 2002, 13, 630-635.
11. Hussack, G.; Grohs, B.M.; Almquist, K.C.; McLean, M.D.; Ghosh, R.; Hall, J.C. Purification of plant-derived antibodies through direct immobilization of affinity ligands on cellulose. J. Agric. Food Chem. 2010, 58, 3451-3459.
12. Floss, D.M.; Conrad, U. Plant Molecular Pharming-Veterinary Applications. Springer Encycl. Sustainability Sci. Technol. 2011, in press.
13. Floss, D.M.; Schallau, K.; Rose-John, S.; Conrad, U.; Scheller, J. Elastin-like polypeptides revolutionize recombinant protein expression and their biomedical application. Trends Biotechnol. 2010, 28, 37-45.
14. Conley, A.J.; Joensuu, J.J.; Richman, A.; Menassa, R. Protein body-inducing fusions for high-level production and purification of recombinant proteins in plants. Plant Biotechnol. J. 2011, 9, 419-433.
15. Floss, D.M.; Mockey, M.; Zanello, G.; Brosson, D.; Diogon, M.; Frutos, R.; Bruel, T.; Rodrigues, V.; Garzon, E.; Chevaleyre, C.; et al. Expression and Immunogenicity of the Mycobacterial Ag85B/ESAT-6 antigens produced in transgenic plants by elastin-like peptide fusion strategy. J. Biomed. Biotechnol. 2010, 2010, 1-15.
16. Floss, D.M.; Sack, M.; Stadlmann, J.; Rademacher, T.; Scheller, J.; Stöger, E.; Fischer, R.; Conrad, U. Biochemical and functional characterization of anti-HIV antibody-ELP fusion proteins from transgenic plants. Plant Biotechnol. J. 2008, 6, 379-391.
17. Floss, D.M.; Sack, M.; Arcalis, E.; Stadlmann, J.; Quendler, H.; Rademacher, T.; Stoger, E.; Scheller, J.R.; Fischer, R.; Conrad, U. Influence of elastin-like peptide fusions on the quantity and quality of a tobacco-derived human immunodeficiency virus-neutralizing antibody. Plant Biotechnol. J. 2009, 7, 899-913.
18. Scheller, J.; Leps, M.; Conrad, U. Forcing single-chain variable fragment production in tobacco seeds by fusion to elastin-like polypeptides. Plant Biotechnol. J. 2006, 4, 243-249.
19. Conrad, U.; Plagmann, I.; Malchow, S.; Sack, M.; Floss, D.M.; Kruglov, A.A.; Nedospasov, S.A.; Rose-John, S.; Scheller, J. ELPylated anti-human TNF therapeutic single-domain antibodies for prevention of lethal septic shock. Plant Biotechnol. J. 2011, 9, 22-31.
20. Meyer, D.E.; Chilkoti, A. Purification of recombinant proteins by fusion with thermally-responsive polypeptides. Nat. Biotechnol. 1999, 17, 1112-1115.
21. Ge, X.; Trabbic-Carlson, K.; Chilkoti, A.; Filipe, C.D.M. Purification of an elastin-like fusion protein by microfiltration. Biotechnol. Bioeng. 2006, 95, 424-432.
22. Capua, I.; Alexander, D.J. Avian influenza: recent developments. Avian Pathol. 2004, 33, 393-404.
23. Capua, I.; Alexander, D.J. Animal and human health implications of avian influenza infections. Biosci. Rep. 2007, 27, 359-372.
24. Shoji, Y.; Chichester, J.A.; Bi, H.; Musiychuk, K.; de la Rosa, P.; Goldschmidt, L.; Horsey, A.; Ugulava, N.; Palmer, G.A.; Mett, V. Plant-expressed HA as a seasonal influenza vaccine candidate. Vaccine 2008, 26, 2930-2934.
25. Shoji, Y.; Farrance, C.E.; Bi, H.; Shamloul, M.; Green, B.; Manceva, S.; Rhee, A.; Ugulava, N.; Roy, G.; Musiychuk, K. Immunogenicity of hemagglutinin from A/Bar-headed Goose/Qinghai/1A/05 and A/Anhui/1/05 strains of H5N1 influenza viruses produced in Nicotiana benthamiana plants. Vaccine 2009, 27, 3467-3470.
26. Mett, V.; Musiychuk, K.; Bi, H.; Farrance, C.E.; Horsey, A.; Ugulava, N.; Shoji, Y.; de la Rosa, P.; Palmer, G.A.; Rabindran, S.; et al. A plant-produced influenza subunit vaccine protects ferrets against virus challenge. Influenza Other Res. Viruses 2008, 2, 33-40.
27. Shoji, Y.; Bi, H.; Musiychuk, K.; Rhee, A.; Horsey, A.; Roy, G.; Green, B.; Shamloul, M.; Farrance, C.E.; Taggart, B. Plant-derived hemagglutinin protects ferrets against challenge infection with the A/Indonesia/05/05 strain of avian influenza. Vaccine 2009, 27, 1087-1092.
28. Kalthoff, D.; Giritch, A.; Geisler, K.; Bettmann, U.; Klimyuk, V.; Hehnen, H.R.; Gleba, Y.; Beer, M. Immunization with plant-expressed hemagglutinin protects chickens from lethal highly pathogenic avian influenza virus H5N1 challenge infection. J. Virol. 2010, 84, 12002-12010.
29. Spitsin, S.; Andrianov, V.; Pogrebnyak, N.; Smirnov, Y.; Borisjuk, N.; Portocarrero, C.; Veguilla, V.; Koprowski, H.; Golovkin, M. Immunological assessment of plant-derived avian flu H5/HA1 variants. Vaccine 2009, 27, 1289-1292.
30. Sylte, M.; Hubby, B.; Suarez, D. Influenza neuraminidase antibodies provide partial protection for chickens against high pathogenic avian influenza infection. Vaccine 2007, 25, 3763-3772.
31. Deroo, T.; Jou, W.M.; Fiers, W. Recombinant neuraminidase vaccine protects against lethal influenza. Vaccine 1996, 14, 561-569.
32. Skehel, J.J.; Wiley, D.C. Receptor binding and membrane fusion in virus entry: The influenza hemagglutinin. Annu. Rev. Biochem. 2000, 69, 531-569.
33. Wandelt, C.I.; Khan, M.R.; Craig, S.; Schroeder, H.E.; Spencer, D.; Higgins, T.J. Vicilin with carboxy-terminal KDEL is retained in the endoplasmic reticulum and accumulates to high levels in the leaves of transgenic plants. Plant J. 1992, 2, 181-192.
34. Conrad, U.; Fiedler, U. Compartment-specific accumulation of recombinant immunoglobulins in plant cells: An essential tool for antibody production and immunomodulation of physiological functions and pathogen activity. Plant Mol. Biol. 1998, 38, 101-109.
35. Scheller, J.; Henggeler, D.; Viviani, A.; Conrad, U. Purification of spider silk-elastin from transgenic plants and application for human chondrocyte proliferation. Transgenic Res. 2004, 13, 51-57.
36. Conley, A.J.; Joensuu, J.J.; Jevnikar, A.M.; Menassa, R.; Brandle, J.E. Optimization of elastin-like polypeptide fusions for expression and purification of recombinant proteins in plants. Biotechnol. Bioeng. 2009, 103, 562-573.
37. Xiang, C.; Han, P.; Lutziger, I.; Wang, K.; Oliver, D. A mini binary vector series for plant transformation. Plant Mol. Biol. 1999, 40, 711-717.
38. Deblaere, R.; Bytebier, B.; de Greve, H.; Deboeck, F.; Schell, J.; van Montagu, M.; Leemans, J. Efficient octopine Ti plasmid-derived vectors for Agrobacterium-mediated gene transfer to plants. Nucleic Acids Res. 1985, 13, 4777-4788.
39. Horsch, R.B.; Fry, J.E.; Hoffmann, N.L.; Eichholtz, D.; Rogers, S.G.; Fraley, R.T. A Simple and General Method for Transferring Genes into Plants. Science 1985, 227, 1229-1231.
40. Potier, M.; Mameli, L.; Belisle, M.; Dallaire, L.; Melancon, S.B. Fluorometric assay of neuraminidase with a sodium (4-methylumbelliferyl-alpha-D-N-acetylneuraminate) substrate. Anal. Biochem. 1979, 94, 287-296.
41. Yongkiettrakul, S.; Boonyapakron, K.; Jongkaewwattana, A.; Wanitchang, A.; Leartsakulpanich, U.; Chitnumsub, P.; Eurwilaichitr, L.; Yuthavong, Y. Avian influenza A/H5N1 neuraminidase expressed in yeast with a functional head domain. J. Virol. Methods 2009, 156, 44-51.